Helicobacter pylori infection accelerates gene expression of glicentin in the gastric mucosa: Its association with intestinal metaplasia of the stomach

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 5, 1997, Pages 460-464

  Ishihara, S ^a   Fukuda, R ^a   Moriyama, N ^a   Ishimura, N ^a   Kaji, T ^a   Kushiyama, Y ^a   Amano, K ^a   Hirakawa, K ^a   Amano, Y ^a   Adachi, K ^a   Ashizawa, N ^a   Fukumoto, S ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Glicentin; Helicobacter pylori; intestinal metaplasia

Indexed keywords

GLICENTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH MUCOSA;

EID: 8244258019     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709025081     Document Type: Article

References (39)

1. Warren JR, Marshall BJ. Unidentified cursed bascillus on gastric epithelium in active chronic gastritis. Lancet 1983;1: 1273-5.
2. Stemmermann GN. Intestinal metaplasia of the stomach. Cancer 1994;74:556-64.
3. Kuipers EJ, Uyterlinede AM, Pena AS, Roosendaal R, Pars G, Nelis G, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
4. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GNJ. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992;33:16-20.
5. Correa P. The new era of cancer epidemiology. Cancer Epidemiol Biomarkers Prevention 1991;1:5-11.
6. Morson BG. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1995;9:377-85.
7. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearance. Gan 1968;54:251-8.
8. Yokozaki H, Tahara E. Genetic alterations in precancerous lesions of the stomach. Cancer Res Clin (In Japanese with English Abstract) 1993;2:148-54.
9. Soman NR, Correa P, Ruiz BA, Wogan GN. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 1991;88:4892-6.
10. Tahara E, Kuniyasu H, Yasui W, Yokozaki H. Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 1994;6 Suppl 1:597-602.
11. Personnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
12. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
13. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
14. Thim L, Moody AJ. The primary structure of porcine glicentin (preproglucagon). Reg Pept 1981;2:139-50.
15. Solcia E, Capella C, Buffa R, Usellini L, Frigerio B, Fontana P. Endocrine cells of the gastrointestinal tract and related tumors. Pathobiol Ann 1979;9:163-204.
16. Bloom SR, Polak JM. Gut hormone overview. In: Bloom SR, editor. Gut hormones. London: Churchill Livingstone, 1978:3-18.
17. Tsutsumi Y, Nagura H, Watanabe K, Yanaihara N. A novel subtyping of intestinal metaplasia of the stomach, with special reference to the histochemical characterizations of endocrine cells. Virchows Arch (Pathol Anat) 1983;401:73-88.
18. Bordi C, Pavazzola M. Endocrine cells in the intestinal metaplasia of gastric mucosa. Am J Pathol 1979;96:391-8.
19. Nielsen HO, Teglbjaerg PS, Hage E. Gastrin and enteroglucagon in human antrum, with special reference to intestinal metaplasia. Scand J Gastroenterol 1979;14:101-3.
20. Tsutsumi Y, Osamura RY, Nagura H, Watanabe K, Yahaihara N. Immunohistochemical studies on gastrointestinal hormones in the intestinal metaplasia of the stomach. In: Miyoshi A, editor. Gut peptide and ulcer. Tokyo: Biochemical Research Foundation, 1983:171-9.
21. Moody AJ, Thim L, Kirkrgaard H. Glicentin: its structure and possible function as an enteroglucagon. In: Miyoshi A, editor. Gut peptides and ulcer. Tokyo: Biochemical Research Foundation, 1983:20-6.
22. Ito H, Yokozaki H, Hata J, Mandai K, Tahara E. Glicentin-containing cells in intestinal metaplasia, adenoma and carcinoma of the stomach. Virchows Arch (Pathol Anat) 1984; 404:17-29.
23. Nanji AA, Zhau S, Sadraden SMH, Waxman DJ. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994;19:1483-7.
24. Suzuki S, Suzuki H, Endo M, Takemoto T, Kondo T, Nakayama K. Endoscopic dyeing method for diagnosis of early cancer and intestinal metaplasia of the stomach. Endoscopy 1973;5:124-8.
25. Fukuda R, Satoh S, Nguyen TX, Uchida Y, Kohge N, Akagi S, et al. Expression of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B. J Gastroenterol 1995;31:41-7.
26. Rothenberg ME, Eilertson CD, Klein K, Zhou Y, Lindverg I, McDonald JM, et al. Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro. J Biol Chem 1995;270: 10136-46.
27. Spicer SS. Diamine methods for differentiating mucosubstances histochemically. J Histochem Cytochem 1965;13:211-34.
28. Satoh K, Kimura K, Yoshida Y, Taniguchi Y, Kasano T, Kihira K, et al. Helicobacter pylori infection and the extension of atrophic gastritis. Eur J Gastroenterol Hepatol 1993;5 Suppl 1:115-7.
29. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267:10570-5.
30. Lopez LC, Frazier ML, Su CJ, Kumura A, Saunders GF. Mammalian pancreatic preproglucagon contains three glucagon-related peptides. Proc Natl Acad Sci USA 1983;80:5485-9.
31. Moody AAJ, Holst JJ, Thim L, Jensen SL. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature 1981;289:514-6.
32. Bloom SR, Polak JM. Enteroglucagon and the gut hormone profile of intestinal adaptation. In: Robinson JWL, Dowling RH, Riecken EO, editors. Mechanism of intestinal adaptation. Lancaster, Boston, The Hague: MTP Press, 1981:189-99.
33. Jacobs LR, Polaak JM, Bloom SR, Dowling RH. Intestinal mucosal and fasting plasma levels of immunoreactive enteroglucagon in three models of intestinal adaptation: resection, hypothermic hyperphagia and lactation in the rat. In: Robinson JWL, Dowling RH, Riecken EO, editors. Mechanism of intestinal adaptation. Lancaster, Boston, The Hague: MTP Press, 1981:231-42.
34. Kimura K, Satoh K, Yoshida Y, Taniguchi Y, Ido K, Takemoto T. Chronological extension of atrophic gastritis and intestinal metaplasia in normal Japanese. Eur J Gastroenterol Hepatol 1993;5 Suppl 1:85-91.
35. Correa P, Haenzel W, Cuello C, et al. Gastric precancerous process in a high-risk population: cohort follow-up. Cancer Res 1990;50:4737.
36. Tsutsumi Y, Nagura H, Watanabe K. Immune aspects of intestinal metaplasia of the stomach - an immunohistochemical study. Virchows Arch (Pathol Anat) 1984;403:345-59.
37. Tsutsumi Y. Pathophysiological significance of intestinal metaplasia of the gastric mucosa - an immunohistochemical approach. In: Kasuya Y, Tsuchiya M, Nagao F, Matsuo Y, editors. Gastrointestinal function. Regulation and distribution 8th ed. Tokyo: Excerpta Medica, 1986;4:15-37.
38. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6635-40.
39. Correa P, Shiaao Y. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994;54:1941s-3s.